Publications by authors named "Deep Rohan Chatterjee"

Claim this Profile
P
Pyruvate kinase M2 - linked metabolic pathways in pain modulation.
Vaishnavi Kalmegh, Lahanya Guha, Deep Rohan Chatterjee, Hemant Kumar, Amit Shard

Drug Discov Today· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IMID-284: a potent pyruvate kinase M2 inhibitor with dual anti-inflammatory and analgesic effects in intervertebral disc disease.
Gyanoday Tripathi, Komal Bhombe, Deep Rohan Chatterjee, Rudradip Das, Divya Goyal

Eur Spine J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imidazopyrimidine-based pyruvate kinase M2 activator halts diabetic nephropathy progression via modulating epithelial-to-mesenchymal transition and fibrosis.
Meenakshi Jain, Adil Ali Sayyed, Piyush Gondaliya, Saumya Kapoor, Deep Rohan Chatterjee

Chem Biol Interact· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, characterization, and microbiological evaluation of new triazolopyrimidine-based ferrocenes as potent antimicrobial prospects.
Sayali Kamble, Deep Rohan Chatterjee, Kakad Shivani Arjun, Saumya Kapoor, Madhav Jadhav

J Inorg Biochem· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of novel tetrazole-based pyruvate kinase M2 inhibitors targeting U87MG glioblastoma cells.
Moumita Ghosh Chowdhury, Saumya Kapoor, Venkatesh Muthukumar, Deep Rohan Chatterjee, Amit Shard

Bioorg Chem· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel sulfonamides unveiled as potent anti-lung cancer agents tumor pyruvate kinase M2 activation.
Rudradip Das, Deep Rohan Chatterjee, Saumya Kapoor, Het Vyas, Amit Shard

RSC Med Chem· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic Investigation of Thiazole-Based Pyruvate Kinase M2 Inhibitor Causing Tumor Regression in Triple-Negative Breast Cancer.
Rudradip Das, Priyanka Pulugu, Aditya A Singh, Deep Rohan Chatterjee, Shraddha Baviskar

J Med Chem· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive characterization and preclinical assessment of an imidazopyridine-based anticancer lead molecule.
Ratik Ramesh Bulbule, Tarang Jadav, Niraj Rajput, Rudradip Das, Deep Rohan Chatterjee

Drug Dev Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Roadmap to Pyruvate Kinase M2 Modulation - A Computational Chronicle.
Saumya Kapoor, Deep Rohan Chatterjee, Moumita Ghosh Chowdhury, Rudradip Das, Amit Shard

Curr Drug Targets· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PROTACting the kinome with covalent warheads.
Deep Rohan Chatterjee, Saumya Kapoor, Meenakshi Jain, Rudradip Das, Moumita Ghosh Chowdhury

Drug Discov Today· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paradigm shift of "classical" HDAC inhibitors to "hybrid" HDAC inhibitors in therapeutic interventions.
Gargi Nikhil Vaidya, Pooja Rana, Ashwini Venkatesh, Deep Rohan Chatterjee, Darshan Contractor

Eur J Med Chem· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis